Abstract 3263: Preclinical characterization of PRT3789, a potent and selective SMARCA2 targeted degrader

Authors: Michael Hulse, Anjana Agarwal, Min Wang, Jack Carter, Monisha Sivakumar, Brian Vidal, Justin Brown, Andrew Moore, Alexander Grego, Neha Bhagwat, Joseph Rager, Liang Lu, Corey Basch, Klare Bersch, Chaofeng Dai, Philip Pitis, Andrew Combs, Bruce Ruggeri, Kris Vaddi, Peggy Scherle, Koichi Ito

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-3263

Source: Full article